These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9513799)

  • 1. Abuse liability of buprenorphine--a study among experienced drug users.
    Bedi NS; Ray R; Jain R; Dhar NK
    Indian J Physiol Pharmacol; 1998 Jan; 42(1):95-100. PubMed ID: 9513799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine effects on morphine- and cocaine-induced subjective responses by drug-dependent men.
    Teoh SK; Mello NK; Mendelson JH; Kuehnle J; Gastfriend DR; Rhoades E; Sholar W
    J Clin Psychopharmacol; 1994 Feb; 14(1):15-27. PubMed ID: 8151000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of differential doses of buprenorphine for long term pharmacotherapy among opiate dependent subjects.
    De S; Jain R; Ray R; Dhawan A; Varghese ST
    Indian J Physiol Pharmacol; 2008; 52(1):53-63. PubMed ID: 18831352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.
    Hakansson A; Medvedeo A; Andersson M; Berglund M
    Eur Addict Res; 2007; 13(4):207-15. PubMed ID: 17851242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective effects of additional doses of buprenorphine in patients on buprenorphine maintenance.
    Singhal A; Tripathi BM; Pal HR; Jena R; Jain R
    Addict Behav; 2007 Feb; 32(2):320-31. PubMed ID: 16814937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation on drug dependence of buprenorphine.
    Liu ZM; Lü XX; Lian Z; Mu Y; Guo P; An X
    Acta Pharmacol Sin; 2003 May; 24(5):448-52. PubMed ID: 12740181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time series modeling of heroin and morphine drug action.
    Tschacher W; Haemmig R; Jacobshagen N
    Psychopharmacology (Berl); 2003 Jan; 165(2):188-93. PubMed ID: 12404073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the abuse liability of buspirone in recreational sedative users.
    Cole JO; Orzack MH; Beake B; Bird M; Bar-Tal Y
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):69-75. PubMed ID: 6130076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
    Blennow G; Fergusson A; Medvedeo A
    Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.
    Lavie E; Fatséas M; Denis C; Auriacombe M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):338-44. PubMed ID: 18824311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE; Bigelow GE; Preston KL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin.
    Oreskovich MR; Saxon AJ; Ellis ML; Malte CA; Reoux JP; Knox PC
    Drug Alcohol Depend; 2005 Jan; 77(1):71-9. PubMed ID: 15607843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abuse liability of diazepam through different routes.
    Singh RK; Jain R; Ray R; Gupta YK
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):181-90. PubMed ID: 11480224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients.
    Lintzeris N; Mitchell TB; Bond A; Nestor L; Strang J
    J Clin Psychopharmacol; 2006 Jun; 26(3):274-83. PubMed ID: 16702892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users.
    Zacny JP; Gutierrez S; Bolbolan SA
    Drug Alcohol Depend; 2005 Jun; 78(3):243-52. PubMed ID: 15893155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of abuse liability of Tramadol among experienced drug users: Double-blind crossover randomized controlled trial.
    Das M; Jain R; Dhawan A; Kaur A
    J Opioid Manag; 2016; 12(6):421-430. PubMed ID: 28059434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
    Lanier RK; Umbricht A; Harrison JA; Nuwayser ES; Bigelow GE
    Addiction; 2007 Oct; 102(10):1648-56. PubMed ID: 17854341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.